Last 12 months
Inside the activity.
13 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 3 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 5 | 3 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2018 Filed Jan 5, 2018 21:46 UTC |
Sanghi SteveDirector
|
GrantCommon Stock | 3,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-18-000195 · f4010318sanghi_myomoinc.xml · nonDerivative · entry 1 SANGHI STEVE · CIK 0001181928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 552,320 Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:42 UTC |
KIRK THOMAS FDirector
|
GrantCommon Stock | 3,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-18-000189 · f4010318kirk_myomoinc.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,457 Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:39 UTC |
Crowley Thomas Aloysius Jr.Director
|
GrantCommon Stock | 3,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-18-000187 · f4010318crowley_myomoinc.xml · nonDerivative · entry 1 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,807 Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 01:39 UTC |
GUDONIS PAUL RChief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001213900-18-000145 · f4010218gudonis_myomo.xml · derivative · entry 4 GUDONIS PAUL R · CIK 0001015994 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F4 · derivative.exercise_date: This stock option shall vest in 24 equal monthly installments over the next two years. F4 · derivative.expiration_date: This stock option shall vest in 24 equal monthly installments over the next two years. Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 01:39 UTC |
GUDONIS PAUL RChief Executive Officer
|
GrantCommon Stock | 22,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-18-000145 · f4010218gudonis_myomo.xml · nonDerivative · entry 3 GUDONIS PAUL R · CIK 0001015994 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472,244 F3 · price: Represents grant of Restricted Stock Units under the Issuer's 2016 Equity Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in quarterly installments over the next two years. Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 01:39 UTC |
GUDONIS PAUL RChief Executive Officer
|
Tax withholdingCommon Stock | 4,226 | $3.65 | $15,424.90 |
DisclosureSEC source: 0001213900-18-000145 · f4010218gudonis_myomo.xml · nonDerivative · entry 2 GUDONIS PAUL R · CIK 0001015994 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 449,744 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock units described in footnote (1). Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 01:39 UTC |
GUDONIS PAUL RChief Executive Officer
|
GrantCommon Stock | 9,863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-18-000145 · f4010218gudonis_myomo.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 453,970 F1 · price: Represents grant of Restricted Stock Units under the Issuer's 2016 Equity Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vested in full on the date of grant. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:40 UTC |
GOLDWASSER RALPH AChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001213900-18-000147 · f4010218goldwasser_myomo.xml · derivative · entry 4 GOLDWASSER RALPH A · CIK 0001015992 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires not disclosed F4 · derivative.exercise_date: This stock option shall vest in 24 equal monthly installments over the next two years. F4 · derivative.expiration_date: This stock option shall vest in 24 equal monthly installments over the next two years. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:40 UTC |
GOLDWASSER RALPH AChief Financial Officer
|
GrantCommon Stock | 17,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-18-000147 · f4010218goldwasser_myomo.xml · nonDerivative · entry 3 GOLDWASSER RALPH A · CIK 0001015992 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,822 F3 · price: Represents grant of Restricted Stock Units under the Issuer's 2016 Equity Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in quarterly installments over the next two years. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:40 UTC |
GOLDWASSER RALPH AChief Financial Officer
|
Tax withholdingCommon Stock | 3,511 | $3.65 | $12,815.15 |
DisclosureSEC source: 0001213900-18-000147 · f4010218goldwasser_myomo.xml · nonDerivative · entry 2 GOLDWASSER RALPH A · CIK 0001015992 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,322 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock units described in footnote (1). Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:40 UTC |
GOLDWASSER RALPH AChief Financial Officer
|
GrantCommon Stock | 8,219 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-18-000147 · f4010218goldwasser_myomo.xml · nonDerivative · entry 1 GOLDWASSER RALPH A · CIK 0001015992 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,833 F1 · price: Represents grant of Restricted Stock Units under the Issuer's 2016 Equity Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vested in full on the date of grant. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:40 UTC |
CONNEIGHTON CLIFFChief Marketing Officer
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001213900-18-000148 · f4010218conneighton_myomo.xml · derivative · entry 3 CONNEIGHTON CLIFF · CIK 0001272037 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F3 · derivative.exercise_date: This stock option shall vest in 24 equal monthly installments over the next two years. F3 · derivative.expiration_date: This stock option shall vest in 24 equal monthly installments over the next two years. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:40 UTC |
CONNEIGHTON CLIFFChief Marketing Officer
|
Tax withholdingCommon Stock | 581 | $3.65 | $2,120.65 |
DisclosureSEC source: 0001213900-18-000148 · f4010218conneighton_myomo.xml · nonDerivative · entry 2 CONNEIGHTON CLIFF · CIK 0001272037 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,250 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock units described in footnote (1). Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:40 UTC |
CONNEIGHTON CLIFFChief Marketing Officer
|
GrantCommon Stock | 1,643 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-18-000148 · f4010218conneighton_myomo.xml · nonDerivative · entry 1 CONNEIGHTON CLIFF · CIK 0001272037 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,831 F1 · price: Represents grant of Restricted Stock Units under the Issuer's 2016 Equity Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vested in full on the date of grant. Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 01:38 UTC |
Mendelsohn DavieVP, Sales
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001213900-18-000144 · f4010218mendelsohn_myomo.xml · derivative · entry 3 Mendelsohn Davie · CIK 0001681079 · VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F3 · derivative.exercise_date: This stock option shall vest in 24 equal monthly installments over the next two years. F3 · derivative.expiration_date: This stock option shall vest in 24 equal monthly installments over the next two years. Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 01:38 UTC |
Mendelsohn DavieVP, Sales
|
Tax withholdingCommon Stock | 2,942 | $3.65 | $10,738.30 |
DisclosureSEC source: 0001213900-18-000144 · f4010218mendelsohn_myomo.xml · nonDerivative · entry 2 Mendelsohn Davie · CIK 0001681079 · VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,338 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock units described in footnote (1). Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 01:38 UTC |
Mendelsohn DavieVP, Sales
|
GrantCommon Stock | 6,575 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-18-000144 · f4010218mendelsohn_myomo.xml · nonDerivative · entry 1 Mendelsohn Davie · CIK 0001681079 · VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,280 F1 · price: Represents grant of Restricted Stock Units under the Issuer's 2016 Equity Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vested in full on the date of grant. Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 01:39 UTC |
Green Brandon MChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001213900-18-000146 · f4010218green_myomo.xml · derivative · entry 3 Green Brandon M · CIK 0001715876 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F3 · derivative.exercise_date: This stock option shall vest in 24 equal monthly installments over the next two years. F3 · derivative.expiration_date: This stock option shall vest in 24 equal monthly installments over the next two years. Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 01:39 UTC |
Green Brandon MChief Medical Officer
|
Tax withholdingCommon Stock | 1,570 | $3.65 | $5,730.50 |
DisclosureSEC source: 0001213900-18-000146 · f4010218green_myomo.xml · nonDerivative · entry 2 Green Brandon M · CIK 0001715876 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,129 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock units described in footnote (1). Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 01:39 UTC |
Green Brandon MChief Medical Officer
|
GrantCommon Stock | 3,698 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-18-000146 · f4010218green_myomo.xml · nonDerivative · entry 1 Green Brandon M · CIK 0001715876 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,698 F1 · price: Represents grant of Restricted Stock Units under the Issuer's 2016 Equity Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vested in full on the date of grant. Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 01:38 UTC |
Naft JonathanVP, General Manager
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001213900-18-000143 · f4010218naft_myomo.xml · derivative · entry 3 Naft Jonathan · CIK 0001680805 · VP, General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F3 · derivative.exercise_date: This stock option shall vest in 24 equal monthly installments over the next two years. F3 · derivative.expiration_date: This stock option shall vest in 24 equal monthly installments over the next two years. Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 01:38 UTC |
Naft JonathanVP, General Manager
|
Tax withholdingCommon Stock | 3,564 | $3.65 | $13,008.60 |
DisclosureSEC source: 0001213900-18-000143 · f4010218naft_myomo.xml · nonDerivative · entry 2 Naft Jonathan · CIK 0001680805 · VP, General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,769 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock units described in footnote (1). Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 01:38 UTC |
Naft JonathanVP, General Manager
|
GrantCommon Stock | 8,219 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-18-000143 · f4010218naft_myomo.xml · nonDerivative · entry 1 Naft Jonathan · CIK 0001680805 · VP, General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,333 F1 · price: Represents grant of Restricted Stock Units under the Issuer's 2016 Equity Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vested in full on the date of grant. Read SEC document |
| January 02, 2018 Filed Jan 9, 2018 23:40 UTC Amendment |
GUDONIS PAUL RDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 3,724 | $3.65 | $13,592.60 |
DisclosureSEC source: 0001213900-18-000305 · f4010418a1gudonis_myomo.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,246 F1 · kind: This Restricted Stock Unit grant vested in full at the date of grant. F2 · kind: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock units described in footnote (1). F3 · shares: This Form 4 is being amended to reflect the correct number of shares surrendered to cover taxes associate with the vesting of restricted stock units. Read SEC document |
| January 02, 2018 Filed Jan 9, 2018 18:38 UTC Amendment |
GOLDWASSER RALPH AChief Financial Officer
|
Tax withholdingCommon Stock | 3,103 | $3.65 | $11,325.95 |
DisclosureSEC source: 0001213900-18-000301 · f4010418a1goldwasser_myomo.xml · nonDerivative · entry 1 GOLDWASSER RALPH A · CIK 0001015992 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,730 F1 · kind: This Restricted Stock Units vested in full on the date of grant. F2 · kind: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock units described in footnote (1). F3 · shares: This Form 4 is being amended to reflect the correct number of shares surrendered to cover taxes associate with the vesting of restricted stock units. Read SEC document |
| January 02, 2018 Filed Jan 9, 2018 18:37 UTC Amendment |
CONNEIGHTON CLIFFChief Marketing Officer
|
Tax withholdingCommon Stock | 536 | $3.65 | $1,956.40 |
DisclosureSEC source: 0001213900-18-000299 · f4010418a1conneighton_myomo.xml · nonDerivative · entry 1 CONNEIGHTON CLIFF · CIK 0001272037 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,295 F1 · kind: This Restricted Stock Unit grant vested in full at the date of grant. F2 · kind: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock units described in footnote (1). F3 · shares: This Form 4 is being amended to reflect the correct number of shares surrendered to cover taxes associate with the vesting of restricted stock units. Read SEC document |
| January 02, 2018 Filed Jan 9, 2018 23:42 UTC Amendment |
Naft JonathanVP, General Manager
|
Tax withholdingCommon Stock | 2,972 | $3.65 | $10,847.80 |
DisclosureSEC source: 0001213900-18-000309 · f4010418a1naft_myomo.xml · nonDerivative · entry 1 Naft Jonathan · CIK 0001680805 · VP, General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,361 F1 · kind: This Restricted Stock Unit grant vested in full at the date of grant. F2 · kind: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock units described in footnote (1). F3 · shares: This Form 4 is being amended to reflect the correct number of shares surrendered to cover taxes associate with the vesting of restricted stock units. Read SEC document |
| January 02, 2018 Filed Jan 9, 2018 23:41 UTC Amendment |
Mendelsohn DavieVP, Sales
|
Tax withholdingCommon Stock | 2,476 | $3.65 | $9,037.40 |
DisclosureSEC source: 0001213900-18-000307 · f4010418a1mendelsohn_myomo.xml · nonDerivative · entry 1 Mendelsohn Davie · CIK 0001681079 · VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,804 F1 · kind: This Restricted Stock Unit grant vested in full at the date of grant. F2 · kind: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock units described in footnote (1). F3 · shares: This Form 4 is being amended to reflect the correct number of shares surrendered to cover taxes associate with the vesting of restricted stock units. Read SEC document |
| January 02, 2018 Filed Jan 9, 2018 23:39 UTC Amendment |
Green Brandon MChief Medical Officer
|
Tax withholdingCommon Stock | 1,389 | $3.65 | $5,069.85 |
DisclosureSEC source: 0001213900-18-000303 · f4010418a1green_myomo.xml · nonDerivative · entry 1 Green Brandon M · CIK 0001715876 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,309 F1 · kind: This Restricted Stock Unit grant vested in full at the time of grant. F2 · kind: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock units described in footnote (1). F3 · shares: This Form 4 is being amended to reflect the correct number of shares surrendered to cover taxes associate with the vesting of restricted stock units. Read SEC document |
| December 04, 2017 Filed Dec 4, 2017 21:06 UTC |
GUDONIS PAUL RDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseWARRANT (RIGHT TO BUY) · Derivative | 10,000 | $0.01 Strike: $2.95 | $100.00 |
DisclosureSEC source: 0001213900-17-012890 · f4120417gudonis_myomo.xml · derivative · entry 2 GUDONIS PAUL R · CIK 0001015994 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2022-12-04 F1 · derivative.exercise_date: The warrants were issued in conjunction with the Company's follow-on offering and will expire at 11:59 p.m. Eastern Time on December 4, 2022. Read SEC document |
| December 04, 2017 Filed Dec 4, 2017 21:06 UTC |
GUDONIS PAUL RDirector · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 10,000 | $2.39 | $23,900.00 |
DisclosureSEC source: 0001213900-17-012890 · f4120417gudonis_myomo.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 444,107 Read SEC document |
| December 04, 2017 Filed Dec 4, 2017 16:04 UTC |
GOLDWASSER RALPH ACHIEF FINANCIAL OFFICER
|
PurchaseWARRANT (RIGHT TO BUY) · Derivative | 15,000 | $0.01 Strike: $2.95 | $150.00 |
DisclosureSEC source: 0001213900-17-012888 · f4120417goldwasser_myomo.xml · derivative · entry 2 GOLDWASSER RALPH A · CIK 0001015992 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2022-12-04 F1 · derivative.exercise_date: The warrants were issued in conjunction with the Company's follow-on offering and will expire at 11:59 p.m. Eastern Time on December 4, 2022. Read SEC document |
| December 04, 2017 Filed Dec 4, 2017 16:04 UTC |
GOLDWASSER RALPH ACHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 15,000 | $2.39 | $35,850.00 |
DisclosureSEC source: 0001213900-17-012888 · f4120417goldwasser_myomo.xml · nonDerivative · entry 1 GOLDWASSER RALPH A · CIK 0001015992 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,614 Read SEC document |
| December 04, 2017 Filed Dec 4, 2017 21:09 UTC |
Sanghi SteveDirector
|
PurchaseWARRANT (RIGHT TO BUY) · Derivative | 250,000 | $0.01 Strike: $2.95 | $2,500.00 |
DisclosureSEC source: 0001213900-17-012894 · f4120417sanghi_myomo.xml · derivative · entry 2 SANGHI STEVE · CIK 0001181928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2022-12-04 F1 · derivative.exercise_date: The warrants were issued in conjunction with the Company's follow-on offering and will expire at 11:59 p.m. Eastern Time on December 4, 2022. Read SEC document |
| December 04, 2017 Filed Dec 4, 2017 21:09 UTC |
Sanghi SteveDirector
|
GrantCommon Stock | 250,000 | $2.39 | $597,500.00 |
DisclosureSEC source: 0001213900-17-012894 · f4120417sanghi_myomo.xml · nonDerivative · entry 1 SANGHI STEVE · CIK 0001181928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 548,513 Read SEC document |
| December 04, 2017 Filed Dec 4, 2017 21:08 UTC |
KIRK THOMAS FDirector
|
PurchaseWARRANT (RIGHT TO BUY) · Derivative | 10,000 | $0.01 Strike: $2.95 | $100.00 |
DisclosureSEC source: 0001213900-17-012892 · f4120417kirk_myomo.xml · derivative · entry 2 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2022-12-04 F1 · derivative.exercise_date: The warrants were issued in conjunction with the Company's follow-on offering and will expire at 11:59 p.m. Eastern Time on December 4, 2022. Read SEC document |
| December 04, 2017 Filed Dec 4, 2017 21:08 UTC |
KIRK THOMAS FDirector
|
GrantCommon Stock | 10,000 | $2.39 | $23,900.00 |
DisclosureSEC source: 0001213900-17-012892 · f4120417kirk_myomo.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,650 Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 16:04 UTC |
GOLDWASSER RALPH AChief Financial Officer
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-17-008887 · f4081517goldwasser_myomo.xml · nonDerivative · entry 1 GOLDWASSER RALPH A · CIK 0001015992 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,614 F1 · shares: Represents a grant of restricted stock under the Company's 2016 Equity Incentive Plan, which vests in full on January 15, 2018. Read SEC document |
| August 15, 2017 Filed Sep 13, 2017 16:16 UTC |
CONNEIGHTON CLIFFChief Marketing Officer
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-17-009637 · f4081517conneighton_myomo.xml · nonDerivative · entry 1 CONNEIGHTON CLIFF · CIK 0001272037 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,188 Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:45 UTC |
GUDONIS PAUL RDirector · CHIEF EXECUTIVE OFFICER
|
Conversion8 % SUBORDINATE CONVERTIBLE NOTE · Derivative | 21,564 | $5.18 | $111,701.52 |
DisclosureSEC source: 0001213900-17-006435 · f4060917gudonis_myomo.xml · derivative · entry 7 GUDONIS PAUL R · CIK 0001015994 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 21,564 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The 8% subordinate convertible note was converted into common stock at a price of $5.18 per share upon completion of the Company's initial public offering. F3 · derivative.exercise_date: The 8% subordinate convertible note was converted into common stock at a price of $5.18 per share upon completion of the Company's initial public offering. F3 · derivative.expiration_date: The 8% subordinate convertible note was converted into common stock at a price of $5.18 per share upon completion of the Company's initial public offering. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:45 UTC |
GUDONIS PAUL RDirector · CHIEF EXECUTIVE OFFICER
|
ConversionSERIES B-1 CONVERTIBLE PREFERRED STOCK · Derivative | 57,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-17-006435 · f4060917gudonis_myomo.xml · derivative · entry 6 GUDONIS PAUL R · CIK 0001015994 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 57,489 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Series B-1 Convertible Preferred Stock converted into common stock on a 1-for-1 basis upon completion of the Company's initial public offering and has no expiration date. F2 · derivative.exercise_date: The Series B-1 Convertible Preferred Stock converted into common stock on a 1-for-1 basis upon completion of the Company's initial public offering and has no expiration date. F2 · derivative.expiration_date: The Series B-1 Convertible Preferred Stock converted into common stock on a 1-for-1 basis upon completion of the Company's initial public offering and has no expiration date. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:45 UTC |
GUDONIS PAUL RDirector · CHIEF EXECUTIVE OFFICER
|
ConversionSERIES A-1 CONVERTIBLE PREFERRED STOCK · Derivative | 69,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-17-006435 · f4060917gudonis_myomo.xml · derivative · entry 5 GUDONIS PAUL R · CIK 0001015994 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 69,726 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A-1 Convertible Preferred Stock converted into common stock on a 1-for-1 basis upon completion of the Company's initial public offering and has no expiration date. F1 · derivative.exercise_date: The Series A-1 Convertible Preferred Stock converted into common stock on a 1-for-1 basis upon completion of the Company's initial public offering and has no expiration date. F1 · derivative.expiration_date: The Series A-1 Convertible Preferred Stock converted into common stock on a 1-for-1 basis upon completion of the Company's initial public offering and has no expiration date. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:45 UTC |
GUDONIS PAUL RDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCOMMON STOCK | 14,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-17-006435 · f4060917gudonis_myomo.xml · nonDerivative · entry 4 GUDONIS PAUL R · CIK 0001015994 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434,107 F4 · price: The Common Stock was acquired in the Company's initial public offering for $7.50 per share. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:45 UTC |
GUDONIS PAUL RDirector · CHIEF EXECUTIVE OFFICER
|
ConversionCOMMON STOCK | 21,564 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-17-006435 · f4060917gudonis_myomo.xml · nonDerivative · entry 3 GUDONIS PAUL R · CIK 0001015994 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The 8% subordinate convertible note was converted into common stock at a price of $5.18 per share upon completion of the Company's initial public offering. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:45 UTC |
GUDONIS PAUL RDirector · CHIEF EXECUTIVE OFFICER
|
ConversionCOMMON STOCK | 57,489 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-17-006435 · f4060917gudonis_myomo.xml · nonDerivative · entry 2 GUDONIS PAUL R · CIK 0001015994 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Series B-1 Convertible Preferred Stock converted into common stock on a 1-for-1 basis upon completion of the Company's initial public offering and has no expiration date. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:45 UTC |
GUDONIS PAUL RDirector · CHIEF EXECUTIVE OFFICER
|
ConversionCOMMON STOCK | 69,726 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-17-006435 · f4060917gudonis_myomo.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A-1 Convertible Preferred Stock converted into common stock on a 1-for-1 basis upon completion of the Company's initial public offering and has no expiration date. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 16:42 UTC |
GOLDWASSER RALPH ACHIEF FINANCIAL OFFICER
|
ConversionSERIES A-1 CONVERTIBLE PREFERRED STOCK · Derivative | 6,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-17-006429 · f4060917goldwasser_myomo.xml · derivative · entry 2 GOLDWASSER RALPH A · CIK 0001015992 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 6,076 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A-1 Convertible Preferred Stock converted into common stock on a 1-for-1 basis upon completion of the Company's initial public offering and has no expiration date. F1 · derivative.exercise_date: The Series A-1 Convertible Preferred Stock converted into common stock on a 1-for-1 basis upon completion of the Company's initial public offering and has no expiration date. F1 · derivative.expiration_date: The Series A-1 Convertible Preferred Stock converted into common stock on a 1-for-1 basis upon completion of the Company's initial public offering and has no expiration date. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 16:42 UTC |
GOLDWASSER RALPH ACHIEF FINANCIAL OFFICER
|
ConversionCOMMON STOCK | 6,076 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-17-006429 · f4060917goldwasser_myomo.xml · nonDerivative · entry 1 GOLDWASSER RALPH A · CIK 0001015992 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A-1 Convertible Preferred Stock converted into common stock on a 1-for-1 basis upon completion of the Company's initial public offering and has no expiration date. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:46 UTC |
Sanghi SteveDirector
|
PurchaseWARRANTS (RIGHT TO BUY) · Derivative | 95,238 | Not disclosed Strike: $7.50 | Not disclosed |
DisclosureSEC source: 0001213900-17-006438 · f4061317sanghi_myomo.xml · derivative · entry 4 SANGHI STEVE · CIK 0001181928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 95,238 shares Expires 2020-06-09 F2 · price: The Common Stock and Warrants were sold in the form of Units issued by the Company in a private placement at a price of $5.25 per Unit, each Unit consisting of one share of Common Stock and a Warrant to purchase one share of Common Stock at an exercise price of $7.50 per share. F3 · derivative.exercise_date: The Warrants are immediately exercisable. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:46 UTC |
Sanghi SteveDirector
|
Conversion8 % SUBORDINATE CONVERTIBLE NOTE · Derivative | 203,275 | $5.18 | $1,052,964.50 |
DisclosureSEC source: 0001213900-17-006438 · f4061317sanghi_myomo.xml · derivative · entry 3 SANGHI STEVE · CIK 0001181928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 203,275 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The 8% subordinate convertible note was converted into common stock at a price of $5.18 per share upon completion of the Company's initial public offering. F1 · derivative.exercise_date: The 8% subordinate convertible note was converted into common stock at a price of $5.18 per share upon completion of the Company's initial public offering. F1 · derivative.expiration_date: The 8% subordinate convertible note was converted into common stock at a price of $5.18 per share upon completion of the Company's initial public offering. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.